NeuroTronik

About:

Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures.

Top Investors: Boston Scientific, Hatteras Venture Partners, Sovereign’s Capital, Mountain Group Capital, MedTech Innovator

Description:

NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,

Total Funding Amount:

$36.6M

Headquarters Location:

Chapel Hill, North Carolina, United States

Founded Date:

2012-01-01

Contact Email:

fred.mccoy(AT)neurotronik.ie

Founders:

William Starling

Number of Employees:

Last Funding Date:

2019-12-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai